{
    "clinical_study": {
        "@rank": "87515", 
        "arm_group": [
            {
                "arm_group_label": "Azelastine group", 
                "description": "Azelastine nasal spray Azelastine eye drops"
            }, 
            {
                "arm_group_label": "Ectoin group", 
                "description": "Ectoin Allergy Nasal Spray Ectoin Allergy Eye Drops"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a comparative, open label, parallel group, non interventional study to further\n      demonstrate the effectiveness and tolerability of Ectoin Allergy Nasal Spray and Eye drops.\n      In addition the effectiveness and safety shall be compared to Azelastine containing nasal\n      Sprays and Eye drops. The patient applied Ectoin\u00ae Rhinitis Nasal Spray / Eye drops or takes\n      Azelastine nasals spray and eye drops according to the instructions for use. The observation\n      takes place over a period of 7 days. Response to treatment is recorded at day 7 by the\n      physician and in daily by the patient in a dairy."
        }, 
        "brief_title": "Application of Ectoine Containing Nasal Spray and Eye Drops in Patients With Allergic Rhinitis", 
        "completion_date": {
            "#text": "September 2010", 
            "@type": "Actual"
        }, 
        "condition": "Allergic Rhinoconjunctivitis", 
        "condition_browse": {
            "mesh_term": [
                "Rhinitis", 
                "Conjunctivitis, Allergic", 
                "Conjunctivitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  male or female patients\n\n          -  aged 18-70 years\n\n          -  Patients with proven allergy and acute symptoms in nose and eye which are treated\n             with Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops or Azelastine Nasal\n             Spray and Azelastine Eye Drops during the observational period\n\n        Exclusion Criteria:\n\n          -  pregnancy and nursing women,\n\n          -  drug addicts and persons unable to give consent to study participation,\n\n          -  patients with intolerance against ingredients of any of the study treatments,\n\n          -  previous eye or nose surgery,\n\n          -  concomitant treatment with anti-allergic drugs, and\n\n          -  diseases which might influence the output of the study according to the physicians'\n             judgment.\n\n          -  contra indications according to the label"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Primary Care Clinic"
            }
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02131051", 
            "org_study_id": "REP-85"
        }, 
        "intervention_browse": {
            "mesh_term": "Tetrahydrozoline"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "ectoine", 
            "allergic rhinitis", 
            "bitop"
        ], 
        "lastchanged_date": "May 5, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Elmshorn", 
                    "country": "Germany"
                }, 
                "name": "HNO Praxis Elmshorn"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "2", 
        "official_title": "Non-interventional Study: Application of Ectoin\u00ae Rhinitis Nasal Spray and Eye Drops in Patients With Allergic Rhinitis", 
        "overall_official": {
            "affiliation": "HNO Praxis Elmshorn", 
            "last_name": "Uwe Sonnemann, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Change in the primary allergic nasal and ophthalmic symptoms:\nDegree of nasal breathing impairment, Rhinorrhea, Frequency of sneezing, Nasal itching,Eye itching, Watery eyes, Conjunctivitis score (eye redness)", 
            "measure": "Change in primary allergic symptoms symptoms", 
            "safety_issue": "No", 
            "time_frame": "Day1, Day 7"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02131051"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Palatal itching score", 
                "safety_issue": "No", 
                "time_frame": "day 1 and day 7"
            }, 
            {
                "description": "Patients assess the efficacy and tolerability separately based on a general  an Scale from 0 to 8", 
                "measure": "Efficacy and tolerability assessment by the patients", 
                "safety_issue": "Yes", 
                "time_frame": "day1 and day 7"
            }
        ], 
        "source": "Bitop AG", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bitop AG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2010", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}